New Zealand markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
57.83+1.04 (+1.83%)
At close: 04:00PM EDT
57.83 0.00 (0.00%)
After hours: 04:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
538,953
486,816
316,385
216,136
208,475
Cost of revenue
208,376
181,513
138,785
100,610
87,157
Gross profit
330,577
305,303
177,600
115,526
121,318
Operating expenses
Research development
38,795
34,286
22,318
11,369
16,001
Selling general and administrative
187,311
161,697
124,044
84,294
64,986
Total operating expenses
285,890
255,774
203,334
143,695
136,888
Operating income or loss
44,687
49,529
-25,734
-28,169
-15,570
Interest expense
21,400
26,940
28,052
11,922
9,452
Total other income/expenses net
12,219
-2,717
-8,879
-15,967
-940
Income before tax
35,506
19,872
-62,665
-56,058
-25,962
Income tax expense
8,491
1,093
-14,769
-13,455
-3,414
Income from continuing operations
27,015
18,779
-47,896
-42,603
-22,548
Net income
27,015
18,779
-47,896
-42,603
-22,548
Net income available to common shareholders
25,390
17,154
-49,521
-42,793
-22,548
Basic EPS
0.55
0.86
-3.05
-3.40
-1.88
Diluted EPS
0.54
0.85
-3.05
-3.40
-1.88
Basic average shares
17,329
18,001
16,260
12,596
11,964
Diluted average shares
17,449
18,194
16,260
12,596
11,964